{"id":"delayed-high-intensity-statin","safety":{"commonSideEffects":[{"rate":null,"effect":"Myalgia / muscle pain"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a delayed-release statin variant intended to optimize pharmacokinetics and potentially improve tolerability or efficacy compared to standard statin formulations. The delayed-release mechanism may reduce peak plasma concentrations and associated adverse effects while maintaining therapeutic LDL-lowering activity. The specific statin active ingredient and exact release mechanism are not publicly detailed.","oneSentence":"A statin formulation designed to achieve high-intensity lipid-lowering effects through delayed or modified release kinetics to reduce LDL cholesterol.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:59.136Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hyperlipidemia / dyslipidemia (primary indication inferred from statin class)"},{"name":"Cardiovascular disease prevention"}]},"trialDetails":[{"nctId":"NCT03635749","phase":"PHASE3","title":"Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2018-09-17","conditions":"Acute Stroke, Transient Ischemic Attack","enrollment":6100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Delayed Atorvastatin"],"phase":"phase_3","status":"active","brandName":"Delayed high-intensity statin","genericName":"Delayed high-intensity statin","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A statin formulation designed to achieve high-intensity lipid-lowering effects through delayed or modified release kinetics to reduce LDL cholesterol. Used for Hyperlipidemia / dyslipidemia (primary indication inferred from statin class), Cardiovascular disease prevention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}